The Intelligent Patient Platform helps companies develop and deliver comprehensive patient programs based on the requirements of unique patient segments. It uses outcome-based analytics to measure the impact of their patient programs (in-person and digital) to refine program effectiveness for each patient segment.
The platform is the underpinning technology for Accenture’s Intelligent Patient Services, a set of evidence-based services to help life sciences companies support patient population journeys from pre-diagnosis through ongoing treatment. These services help companies redefine how they incorporate the patient experience into the development, launch and support of their innovative science.
Currently being used by more than 10 global companies – including pharmaceutical, biotech, medical device and patient support services (HUBs).
Fully configurable, able to be tailored by therapeutic and patient populations.
Supports both US and global markets.
Informed by our work with 21 of the top 25 life sciences companies developing patient services programs.
Utilizes evidence-driven business models through a real-world data repository of over 50 million electronic medical records.
Get to know the Accenture Patient Experience Manager—a new solution that helps life sciences companies monitor, measure and improve their patient interactions across all their patient services programs.
Read about how we’re putting the platform in action with our clients:
Accenture Collaborates with Salesforce to Extend Capabilities of Salesforce Health Cloud, Provides Life Sciences Companies and Healthcare Providers with an Integrated Solution to Improve Patient Support
|Patients receive quicker and easier access to therapies with better support from health systems to manage their condition.|
|Payers get accurate documentation to process a patient’s potential benefits request more quickly and easily.|
|Providers get increased support towards their patient care imperatives of quality, affordability and engagement (triple aim).|
|Specialty pharmacies get access to prescription information that can remove unnecessary follow-ups with physicians and patients.|